NCT07121764

Brief Summary

This study is being done to find out which medicine combination provides better pain relief after surgery in children. Children who are having surgery below the belly button (called infra-umbilical surgery) will receive general anesthesia and a type of pain-blocking injection called a caudal block. This block helps reduce pain after surgery. The study will compare two types of caudal injections: One group will receive Bupivacaine alone, a commonly used local anesthetic. The other group will receive Bupivacaine combined with Dexmedetomidine, a medicine that might help the pain relief last longer. The main question the researchers want to answer is: Does adding Dexmedetomidine to Bupivacaine increase the duration of pain relief after surgery in children? Researchers will also look at: How long it takes before the child needs the first dose of pain medicine after surgery How much pain medicine is used in the first 24 hours How long any movement problems (motor block) last Whether there are any side effects Each child will be randomly assigned (like flipping a coin) to one of the two groups. The caudal block will be done after the surgery is completed, while the child is still under anesthesia. The nurse assessing the child's pain will not know which medicine the child received. Children will be monitored for pain using a standard scoring system (FLACC scale) every few hours after surgery. If the pain score is high (7 or more), the child will receive intravenous paracetamol. Researchers will record how long the pain relief lasts, when the first pain medicine is needed, and the total amount of pain medicine used in the first 24 hours. The study aims to help doctors choose the most effective and safe method to reduce post-surgery pain in children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2025

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 27, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

August 7, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 13, 2025

Completed
Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

August 7, 2025

Last Update Submit

August 7, 2025

Conditions

Keywords

BupivacaineDexmedetomidineCaudal blockPediatricsPostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Analgesia Duration

    Duration of post-operative pain free time (hours): time from surgery to FLACC score ≥7 needing rescue analgesia

    From surgery to 24-hours post operatively

Other Outcomes (1)

  • Analgesia Consumption

    From surgery to 24-hours post operatively

Study Arms (2)

Monotherapy

ACTIVE COMPARATOR

Bupivacaine alone

Drug: Bupivacaine %0.25 (isobaric)

Combination therapy

EXPERIMENTAL

Bupivacaine with Dexmedetomidine

Drug: Dexmedetomidine & Bupivacaine.

Interventions

1 ml/kg of 0.25% Bupivacaine will be used for caudal block.

Monotherapy

1 ml/kg of 0.25% Bupivacaine PLUS 1 μg/kg Dexmedetomidine in 1 ml Normal Saline will be used for caudal block.

Combination therapy

Eligibility Criteria

Age1 Year - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Elective infra-umbilical Surgeries
  • ASA Status I and II

You may not qualify if:

  • Chronic systemic illness (cardiovascular, pulmonary or renal disease, hepatic impairment)
  • Allergy to local anesthetics
  • Coagulation disorder
  • Local skin infection
  • Neuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Allama Iqbal Teaching Hospital

Dera Ghazi Khan, Punjab Province, 32200, Pakistan

Location

Related Publications (2)

  • Saadawy I, Boker A, Elshahawy MA, Almazrooa A, Melibary S, Abdellatif AA, Afifi W. Effect of dexmedetomidine on the characteristics of bupivacaine in a caudal block in pediatrics. Acta Anaesthesiol Scand. 2009 Feb;53(2):251-6. doi: 10.1111/j.1399-6576.2008.01818.x. Epub 2008 Dec 6.

    PMID: 19076110BACKGROUND
  • Goyal V, Kubre J, Radhakrishnan K. Dexmedetomidine as an adjuvant to bupivacaine in caudal analgesia in children. Anesth Essays Res. 2016 May-Aug;10(2):227-32. doi: 10.4103/0259-1162.174468.

    PMID: 27212752BACKGROUND

MeSH Terms

Conditions

Hypospadias

Interventions

DexmedetomidineBupivacaine

Condition Hierarchy (Ancestors)

Urogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPenile DiseasesGenital Diseases, MaleGenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Syed A Abbas Naqvi, FCPS

    Allama Iqbal Teaching Hospital Dera Ghazi Khan

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 7, 2025

First Posted

August 13, 2025

Study Start

April 27, 2025

Primary Completion

July 26, 2025

Study Completion

July 26, 2025

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations